Listed

Wintrust Financial Corp: Form 10-K for the period ended Dec 31, 2022

Filed with the SEC on Feb 28, 2023 and accepted by EDGAR at Feb 28, 2023, 17:27 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2022-01-01 to 2022-12-31$217.7mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Interest expense12 months2022-01-01 to 2022-12-31$252.1mus-gaap:InterestExpense
Income tax12 months2022-01-01 to 2022-12-31$190.9mus-gaap:IncomeTaxExpenseBenefit
Net income12 months2022-01-01 to 2022-12-31$509.7mus-gaap:NetIncomeLoss
Diluted EPS12 months2022-01-01 to 2022-12-31$8.02us-gaap:EarningsPerShareDiluted
Basic EPS12 months2022-01-01 to 2022-12-31$8.14us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2022-01-01 to 2022-12-3160,091,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2022-01-01 to 2022-12-31$1.38bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2022-01-01 to 2022-12-31$53.4mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid12 months2022-01-01 to 2022-12-31$108.2mus-gaap:PaymentsOfDividends
Share repurchases12 months2022-01-01 to 2022-12-31$0us-gaap:PaymentsForRepurchaseOfCommonStock
Total assetsAt period end2022-12-31$52.95bnus-gaap:Assets
Total liabilitiesAt period end2022-12-31$48.15bnus-gaap:Liabilities
Short-term borrowingsAt period end2022-12-31$17.6mus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2022-12-31$4.80bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001015328-23-000070. Last ingested by Listed: Nov 5, 2026, 14:04 ET. Listed shows no prices and gives no investment advice.